UNSPSC 51386100: Nonsteroidal anti inflammatory sulindacs

Nonsteroidal anti inflammatory drugs made of a sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic.

UNSPSC 51386100 Nonsteroidal anti-inflammatory sulindacs is a Class code that does not align with the recent state and local contract opportunities tagged under it. The code nominally describes a specific pharmaceutical product class, but the three most recent opportunities—a naloxone and drug deactivation systems procurement, a therapeutic pharmacy direct-to-manufacturer RFI, and a multistate cooperative generic pharmaceutical and OTC products RFP—cover emergency medical supplies, pharmacy benefit program strategy, and broad generic pharmaceutical distribution rather than nonsteroidal anti-inflammatory drugs. The mismatch suggests tagging inconsistency in the source system rather than active market demand for sulindac specifically under this code.

The recent activity does show state health agencies and cooperative purchasing coalitions actively procuring pharmaceuticals and related medical supplies through formal competitive vehicles. Issuing bodies include county health departments (Seminole County, Florida), state HHS commissions (Texas), and multistate cooperative purchasing alliances (Minnesota MMCAP). Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries due July 26, 2023; the Texas HHS Commission's April 2026 RFI on direct-to-manufacturer prescription programs; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026, and contract effectiveness July 1, 2026. Geographic activity spans Florida, Texas, and the Upper Midwest (Minnesota and Oregon through cooperative purchasing). Vendors pursuing this code should verify current tagging accuracy and focus on active multistate pharmaceutical supply contracts rather than sulindac specifically, as that product category shows no recent solicitation activity.